Skip to main
NHI

NHI Stock Forecast & Price Target

NHI Analyst Ratings

Based on 6 analyst ratings
Buy
Strong Buy 17%
Buy 50%
Hold 33%
Sell 0%
Strong Sell 0%

Bulls say

National Health Investors is a promising investment opportunity with potential for long-term growth. This is due to its low-levered balance sheet, attractive cost of capital, and deep investment pipeline with accretive yields. The recent pullback in stock price presents an attractive entry point for investors, and the company's role as an operator of senior housing assets provides a stable revenue stream. With the recent portfolio sale, the company has the potential for significant capital gains and a potential for a competing bid from a third party, making it an attractive investment option.

Bears say

National Health Investors is facing challenges including difficulties with certain operators, high concentration risk, and potential weakness in acquisition volumes/pricing and interest rates. The company's recent portfolio sale may not have been the best option, and we are skeptical of the potential for future growth given the lack of attractive opportunities to redeploy the proceeds. However, the company's strong balance sheet and diversification in the healthcare sector are positive points, and we will maintain a Buy rating on its shares given the potential for growth in the Shop segment and its attractive dividend yield.

NHI has been analyzed by 6 analysts, with a consensus rating of Buy. 17% of analysts recommend a Strong Buy, 50% recommend Buy, 33% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of National Health Investors and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About National Health Investors (NHI) Forecast

Analysts have given NHI a Buy based on their latest research and market trends.

According to 6 analysts, NHI has a Buy consensus rating as of Sep 28, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $83.33, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $83.33, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

National Health Investors (NHI)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.